Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Bronchology Interv Pulmonol. 2018 Apr;25(2):88–96. doi: 10.1097/LBR.0000000000000401

Table 1.

Baseline Subject Characteristics

Characteristic Study subjects (n=104)
Age, yr 58.2 (20 – 83)
Male Gender 58 (55.8)
Smoking status
 Never 52 (50)
 Current 11 (10.6)
 Former 41 (39.4)
 Pack/years smoked 20.1 ± 20.4
Outpatient 91 (87.5)
HRCT: UIP designation
 UIP pattern 7 (6.7)
 Possible UIP 11 (10.6)
 Inconsistent with UIP 86 (82.7)
Pulmonary Function Tests
 FVC, L 2.8 ± 0.97
 FVC, % predicted 70.2 ± 17.9
 FEV1, L 2.2 ± 0.69
 FEV1, % predicted 71.2 ± 17.2
 TLC, L 4.3 ± 1.3
 TLC, % predicted 70.2 ± 18.3
 DLCO, mm/min/mmHg 14.6 ± 7.0
 DLCO, % predicted 59.1 ± 22.6
Respiratory status
 SpO2 96.3 ± 5
 Supplemental oxygen at baseline 18 (17.3)
 S:F ratio <315 9 (8.6)

Values presented as number (percentage) or mean ± standard deviation, unless otherwise noted. DLCO is reported corrected for hemoglobin, when available. DPLD = diffuse parenchymal lung disease; FVC = forced vital capacity; FEV1 = forced expiratory volume in the first second; TLC = total lung capacity; DLCO = diffusing capacity for carbon monoxide; SpO2 = pulse oximetric saturation; S:F ratio = SpO2 divided by fraction of inspired oxygen (FiO2).

Presented as mean (range).

Correlates with PaO2:FiO2 ratio of 300.16